dr. D. Postmus

No picture available
E-mail:
d.postmus umcg.nl

Research

  1. 2020
  2. DAPA-CKD Trial Committees and Investigators, McMurray, J. J. V., Wheeler, D. C., Stefánsson, B. V., Jongs, N., Postmus, D., Correa-Rotter, R., Chertow, G. M., Greene, T., Held, C., Hou, F. F., Mann, J. F. E., Rossing, P., Sjöström, C. D., Toto, R. D., Langkilde, A. M., & Heerspink, H. J. L. (2020). Effect of Dapagliflozin on Clinical Outcomes in Patients with Chronic Kidney Disease, With and Without Cardiovascular Disease. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.120.051675
  3. 2019
  4. Biegus, J., Demissei, B., Postmus, D., Cotter, G., Davison, B. A., Feker, G. M., Filippatos, G., Gimpelewicz, C., Greenberg, B., Metra, M., Severin, T., Teerlink, J. R., Voors, A. A., & Ponikowski, P. (2019). Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trial. ESC Heart Failure. https://doi.org/10.1002/ehf2.12477
  5. Russo, S., Jongerius, C., Faccio, F., Pizzoli, S. F. M., Pinto, C. A., Veldwijk, J., Janssens, R., Simons, G., Falahee, M., de Bekker-Grob, E., Huys, I., Postmus, D., Kihlbom, U., & Pravettoni, G. (2019). Understanding Patients' Preferences: A Systematic Review of Psychological Instruments Used in Patients' Preference and Decision Studies. Value in Health, 22(4), 491-501. https://doi.org/10.1016/j.jval.2018.12.007
  6. 2018
  7. Postmus, D., Richard, S., Bere, N., van Valkenhoef, G., Galinsky, J., Low, E., Moulon, I., Mavris, M., Salmonsson, T., Flores, B., Hillege, H., & Pignatti, F. (2018). Individual Trade-Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma. The Oncologist, 23(1), 44-51. https://doi.org/10.1634/theoncologist.2017-0257
  8. van Boven, N., Kardys, I., van Vark, L. C., Akkerhuis, K. M., de Ronde, M. W. J., Khan, M. A. F., Merkus, D., Liu, Z., Voors, A. A., Asselbergs, F. W., van den Bos, E-J., Boersma, E., Hillege, H., Duncker, D. J., Pinto, Y. M., & Postmus, D. (2018). Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure. European Journal of Heart Failure, 20(1), 89-96. https://doi.org/10.1002/ejhf.950
  9. 2017
  10. van Vark, L. C., Lesman-Leegte, I., Baart, S. J., Postmus, D., Pinto, Y. M., de Boer, R. A., Asselbergs, F. W., Wajon, E. M. C. J., Orsel, J. G., Boersma, E., Hillege, H. L., Akkerhuis, K. M., & TRIUMPH (Translational Initiative on Unique and Novel Strategies for Management of Patients with Heart Failure) Investigators (2017). Prognostic Value of Serial Galectin-3 Measurements in Patients With Acute Heart Failure. Journal of the American Heart Association, 6(12), [003700]. https://doi.org/10.1161/JAHA.116.003700
  11. van Vark, L. C., Lesman-Leegte, I., Baart, S. J., Postmus, D., Pinto, Y. M., Orsel, J. G., Westenbrink, B. D., Brunner-la Rocca, H. P., van Miltenburg, A. J. M., Boersma, E., Hillege, H. L., Akkerhuis, K. M., & TRIUMPH Investigators (2017). Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure. Journal of the American College of Cardiology, 70(19), 2378-2388. https://doi.org/10.1016/j.jacc.2017.09.026
  12. Liu, L. C. Y., Valente, M. A. E., Postmus, D., O'Connor, C. M., Metra, M., Dittrich, H. C., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B., Cleland, J. G. F., Givertz, M. M., Bloomfield, D. M., van Veldhuisen, D. J., Hillege, H. L., van der Meer, P., & Voors, A. A. (2017). Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial. Cardiovascular Drugs and Therapy, 31(3), 281-293. https://doi.org/10.1007/s10557-017-6726-1
  13. Demissei, B. G., Postmus, D., Cleland, J. G., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B. A., Givertz, M. M., Bloomfield, D. M., van Veldhuisen, D. J., Dittrich, H. C., Hillege, H. L., & Voors, A. A. (2017). Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure. European Journal of Heart Failure, 19(6), 728-738. https://doi.org/10.1002/ejhf.766
  14. 2016
  15. Demissei, B. G., Postmus, D., Liu, L. C. Y., Cleland, J. G., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J. R., Cotter, G., Davison, B. A., Edwards, C., Givertz, M. M., Bloomfield, D. M., Dittrich, H. C., Voors, A. A., & Hillege, H. L. (2016). Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure - Post-hoc analysis of the PROTECT trial. International Journal of Cardiology, 223, 967-975. https://doi.org/10.1016/j.ijcard.2016.08.271
  16. Biegus, J., Hillege, H. L., Postmus, D., Valente, M. A. E., Bloomfield, D. M., Cleland, J. G. F., Cotter, G., Davison, B. A., Dittrich, H. C., Fiuzat, M., Givertz, M. M., Massie, B. M., Metra, M., Teerlink, J. R., Voors, A. A., O'Connor, C. M., & Ponikowski, P. (2016). Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study. European Journal of Heart Failure, 18(7), 830-839. https://doi.org/10.1002/ejhf.532
  17. Demissei, B., Postmus, D., Liu, L., Cleland, J., O'Connor, C. M., Metra, M., Ponikowski, P., Teerlink, J., Cotter, G., Davison, B., Givertz, M., Bloomfield, D., Dittrich, H., Voors, A., & Hillege, H. (2016). Heterogeneity in efficacy of rolofylline using a risk-based evaluation in patients hospoitalized with acute heart failure. Journal of the American College of Cardiology, 67(13), 1440-1440.
  18. 2015
  19. Pignatti, F., Ashby, D., Brass, E. P., Eichler, H-G., Frey, P., Hillege, H. L., Hori, A., Levitan, B., Liberti, L., Loefstedt, R. E., McAuslane, N., Micaleff, A., Noel, R. A., Postmus, D., Renn, O., Sabourin, B. J., Salmonson, T., & Walker, S. (2015). Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions. Clinical Pharmacology & Therapeutics, 98(5), 522-533. https://doi.org/10.1002/cpt.203
  20. 2014
  21. Givertz, M. M., Postmus, D., Hillege, H. L., Mansoor, G. A., Massie, B. M., Davison, B. A., Ponikowski, P., Metra, M., Teerlink, J. R., Cleland, J. G. F., Dittrich, H. C., O'Connor, C. M., Cotter, G., & Voors, A. A. (2014). Renal Function Trajectories and Clinical Outcomes in Acute Heart Failure. Circulation-Heart failure, 7(1), 59-67. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000556
  22. 2013
  23. Battes, L., Kardys, I., Barendse, R., Steyerberg, E. W., Amiri, M., Eijkemans, M. J. C., Deckers, J. W., Postmus, D., Takkenberg, J. J. M., Redekop, K., & Boersma, E. (2013). Microsimulation for Clinical Decision-Making in Individual Patients With Established Coronary Artery Disease - A Concept. Circulation journal, 77(3), 717-724. https://doi.org/10.1253/circj.CJ-11-1300
  24. 2012
Previous 1 2 Next

ID: 246766